Ventyx Biosciences, Inc.
VTYX
$2.51
$0.020.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.86% | 37.22% | 34.76% | 40.00% | 0.92% |
| Total Depreciation and Amortization | -12.75% | -21.84% | 16.60% | 127.34% | 204.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.77% | -21.83% | -51.64% | -43.76% | 0.45% |
| Change in Net Operating Assets | 85.18% | 129.12% | -125.41% | 363.22% | -512.46% |
| Cash from Operations | 46.00% | 54.99% | -2.30% | 50.21% | -54.02% |
| Capital Expenditure | 90.86% | 97.16% | 100.00% | 69.23% | -191.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.98% | -123.72% | -24.89% | -315.51% | 322.67% |
| Cash from Investing | -36.75% | -123.84% | -24.80% | -316.89% | 321.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -48.85% | -99.30% | -- | 97.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -104.27% | 1,553.05% | -136.64% | 97.72% |
| Foreign Exchange rate Adjustments | 2,480.00% | -170.93% | 1,100.00% | -123.68% | -125.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.10% | -585.85% | 255.15% | -744.82% | 7,953.83% |